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Abstract: Since its inception on December 2019, COVID-19 epidemic now has been titled a global emergency. Rich liter-
ature on the global descriptive epidemiology of the cases has shown that the burden of COVID-19 epidemic in
terms of both morbidity and mortality is more pronounced among men. Physiological and genetic traits along
with numerous differences in social and cultural profile of men are attributed to this discrepancy. This review
attempted to delineate various proposed explanations for the observed gender-differences in COVID-19 mor-
bidity and mortality.
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1. Introduction
In early December 2019, an outbreak of a novel coronavirus
disease (COVID-19) emerged in Wuhan city and rapidly
spread throughout China and the world (1). The exponen-
tial and rapid growth of the epidemic has made the World
Health Organization to announce COVID-19 outbreak as the
sixth public health emergency of international concern on
30 January 2020, following H1N1 (2009), polio (2014), Ebola
in West Africa (2014), Zika (2016) and Ebola in the Demo-
cratic Republic of Congo (2019) (2). Epidemiologic evidence
shows that the trend of the incidence of COVID-19 largely
follows exponential growth, so that by 1st of April 2020, the
number of confirmed cases worldwide has exceeded 823,626
confirmed and 40,598 deaths (3). Although the situation
is evolving and further updated data are required to con-
firm, the calculations show that the mean basic reproduc-
tion number (R0 ) was estimated to range from 2.24 [95%
confidence interval (CI) 1.96–2.55] to 3.58 (95% CI 2.89–4.39),
associated with two- to eight-fold increases in the report-
ing rate (4, 5). The current estimate of the mean incuba-
tion period for COVID-19 is 6.4 days, ranging from 2.1 days to
11.1 days (2.5th to 97.5th percentile), with potential asymp-
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tomatic transmission (6). Iran identified the COVID-19 epi-
demic by two deaths on 20th February 2020 and currently it
is ranked among the 15 first countries with the highest mor-
bidity and mortality in the world. A glance on the descriptive
epidemiology of the cases in Iran shows that the mean age of
the cases was 52.7 years. Interestingly, compared to women,
men can acquire CoV infection up to 13% higher and may die
from the disease 29% more (Table 1) (7) . Meanwhile, identifi-
cation of risk factors for morbidity and mortality from CoV is
urgently warranted not only to define clinical and epidemi-
ological characteristics more precisely, but also to facilitate
control and containment measures to cease the epidemic (1).
Despite this need, gender-dependence nature of the COVID-
19 epidemic has been the focus of little literature. Therefore,
this review is prepared to address the COVID-19 epidemic
among men. To prepare this narrative review, the major in-
ternational (including Medline, Scopus, and Clarivate Ana-
lytics) and national (Magiran, SID) electronic databases were
searched to obtain published research with the keywords in-
cluding COVID-19, CoV infection, Corona Virus, Respiratory
virus, gender-difference, and male susceptibility. Studies
with the aim to explain gender variations or male susceptibil-
ity to CoV infection were as priority. In addition to published
literature, opinions of experts in the field of men‘s health and
infectious diseases were collected and summarized.
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2. Male susceptibility to Corona Virus
(CoV) infection
Epidemiological studies show sex-specific differences in the
incidence and Case Fatality Rates (CFRs) in human hosts
after CoV infection, with males experiencing higher CFRs
compared with females (8, 9). Investigations from mainland
China showed that men manifest more serious forms of the
disease during COVID-19 epidemic compared to women. Al-
though age was comparable between men and women in the
deceased or the survived group, the proportion of male was
higher in the deceased group than in the survived group (70.3
vs. 50.0) (10, 11). Male dominance in cases of COVID-19
has been reported by other countries as well (12-14). Pub-
lished factsheets by the Iranian ministry of health & medical
education show that throughout the COVID-19 pandemic,
men acquire the CoV disease 13% more and die of the dis-
ease 29% more than women (7). The sex-dependent increase
in disease severity after pathogenic CoV infection was more
pronounced with advancing age (15). Results from Iranian
patients have shown that compared to women, there was a
male dominance in morbidity among age groups of 30-39
and 40-49 years old and in mortality among 50-59 and 60-
69 years old. A report of one tertiary hospital in Tehran city
(Shohadaye-Tajrish Referral Hospital) showed that during 41
days (until the date of the final drafting of this article), a to-
tal of 1100 cases of CoV have been admitted to the hospi-
tal with a male-to-female ratio of 1.7 (from official weekly
reports of the corresponding hospital). The reasons behind
gender discrepancy in morbidity and mortality from CoV in-
fection are not fully explored. A few in vitro studies have
attempted to find the answer while epidemiologic evidence
is still hugely lacking. Therefore, the rest of this review ad-
dressed two broad categories of explanations based on ge-
netic traits and social characteristics. Although, more basic
and clinical research regarding the role of gender for individ-
ualized treatment and risk prediction is needed.
2.1. Genetic and physiologic explanation
Similar to SARS, CoV attacks cells via the same receptor,
ACE2. It has previously reported that high protein expres-
sion of ACE2 receptor in specific organs correlated with
specific organ failures indicated by corresponding clinical
parameters in SARS patients (16, 17). Interestingly, the
ACE2 gene is located on the X-chromosome and it has been
shown that circulating ACE2 levels are higher in men than
in women (18). Apart from ACE2 expression, expressions
of pro-inflammatory cytokine (IL-6) and chemokine (CCL2
and CXCL1) are also presented as the possible mechanism
for higher susceptibility to CoV infection among male. It
is reported that following CoV challenge, the levels of these
cytokines and chemokines remained elevated or even in-
creased in lungs of male mice compared with females, sug-
gesting a prolonged inflammatory response in male mice
(19). Corona virus predominantly replicates in airways and
alveolar epithelial cells (20) while estradiol concentrations
are higher in female mice (21). Estrogen signaling in females
may directly suppress SARS-CoV replication via effects on
cellular metabolism. Moreover, high viral RNA levels in the
lungs of male mice may stimulate TLR7 on IMMs, resulting in
elevated pro-inflammatory cytokines and chemokines (22).
Higher virus titers and increased IMM and neutrophil infil-
tration in the lungs suggest the contribution of multiple fac-
tors to the disease severity observed in male mice. Increased
numbers of IMMs and neutrophils in SARS-CoV infected
males correlated with elevated levels of pro-inflammatory cy-
tokines and chemokines in the lungs of male mice are also
reported from other studies. These cells also produced more
of these inflammatory mediators in male mice compared
with female mice. Further, increased numbers of IMMs in
ovariectomized mice compared with intact female mice sug-
gest that estrogen signaling in females suppressed the ac-
cumulation and function of IMMs in the lungs (23) . The
higher expression of ACE2 in men can be regarded as an ex-
planation to the higher mortality among them, though fur-
ther research on the mechanism is needed. Another factor
that could contribute to different outcomes of CoV disease
between men and women is the direct cytopathic effect that
is due to higher virus loads in males(24). Human studies are
also conducted to find the link between male gender and sus-
ceptibility to CoV infection. Multiple factors have been iden-
tified that contribute to disparity in sex-specific disease out-
comes following virus infections. Sex-specific steroids and
activity of X-linked genes, both of which modulate the in-
nate and adaptive immune response to virus infection, may
influence the immune response (25, 26). Meanwhile, some
studies used simulations of body response to other infec-
tious pathogens to the problem in hand. Similar to HIV in-
fection, it is shown that high copy numbers of TLR7 (located
on the X-chromosome) and elevated IRF-7 expression in fe-
males induce increased IFN-b production by plasmacytoid
dendritic cells and provided protection against HIV infection
in female patients (27). Additionally, estrogens are known to
suppress monocyte–macrophage recruitment by downreg-
ulating CCL2 expression during inflammation and inhibit-
ing TLR4-mediated NFkb activation in macrophages via sup-
pression of micro-RNAs, such as let7a and miR-125b. Simi-
larly, it has been shown that treating with estrogen reduces
the levels of TNF and CCL2 and, thus, protects against in-
fluenza virus infection(28, 29). In summary, results of ge-
netic studies show that male gender is probably more suscep-
tible to CoV infection compared with age-matched females.
These results are in accordance with what is previously been
observed in SARS and MERS studies in humans, showing
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Table 1: Gender stratified distribution of morbidity and mortality of CoV infection in Iran by 31s t March 2020
Men N(%)* Women N(%)
CoV morbidity 23730 (53.2) 20876 (46.8)
CoV mortality 1637 (56.5) 1261 (43.5)
*based on the total number of cases reported from the Ministry of Health and Medical Education.
that there is a trend toward sex-specific disease outcomes in
middle-aged individuals compared with younger individuals
(8, 15, 30). Nonetheless, considering unique characteristics
of infectious diseases, there are still many research opportu-
nities on the role of genetic traits on pathogenesis of CoV in-
fection in humans. So far, the role of ACE2, IMMs, cytokines
and inflammatory biomarkers are partially explored while
personalized medicine and prevention measures would re-
quire more insights into genome-wide association studies.
2.2. Epidemiologic explanation
To our surprise, sex-differences in the distribution of CoV in-
fection in human population received little attention from
epidemiologic perspective. Despite ample epidemiologic ev-
idence on the description of COVID-19 cases and fatalities,
proposed hypotheses on the observed differences are scarce.
It is frequently reported that differences in morbidity and
mortality from COVID-19 were less apparent in individuals
aged over 75 years, possibly because of the enhanced mortal-
ity in elderlies, regardless of sex (13, 30). On the other hand,
balanced sex distribution of cases in advanced ages might be
due to the presence of other co-morbidities and underlying
diseases, which affects the survival equally. For instance, un-
stratified on gender, cardiovascular disease and hyperten-
sion were the most common underlying diseases, followed by
diabetes mellitus among Iranian adult patients (7) . Thus, it is
likely that the effects of genetic traits (presumably ACE2) en-
hancing susceptibility in men are antagonized by the clinical
profile of the patients, leading to sex-independent progno-
sis among elderlies. This explanation is in accordance with
studies from China suggesting that COVID-19 is more likely
to affect older cases with comorbidities, and can result in se-
vere and even fatal respiratory diseases such as respiratory
distress (10, 11, 18). Another plausible explanation is the rela-
tionship between CoV infection and tobacco smoking. Stud-
ies on the clinical management of the disease have demon-
strated that smoking is related to higher expression of ACE2
(the receptor for severe acute respiratory syndrome coron-
avirus 2), so that might also be a reason for observed sex-
differences in COVID-19 prevalence and severity (31). Con-
sistent to the observation in China (31), the sex predispo-
sition in the distribution of CoV infection might be associ-
ated with the much higher smoking rate in men. One study
(preprint) found that despite similar expression of ACE2 be-
tween men and women, it was significantly higher in cur-
rent smokers of Asian ethnicity than non-smokers (32). Other
studies, mainly in China, have also shown a trend towards
an association between smoking and severity of COVID-19
(33, 34); nevertheless, the current literature does not sup-
port smoking as a predisposing factor in men for infection
with CoV. Additionally, reports on the distribution of COVID-
19 cases with regard to smoking status are not prepared in
Iran yet. To establish whether tobacco smoking contributes
to susceptibility to COVID-19 among men, strong local evi-
dence of an association between smoking and prevalence or
severity of COVID-19 in Iranian men are highly warranted.
On another perspective, higher incidence rate of CoV in men
might be due to higher social interactions in work places.
National office for statistics reported that men comprises of
81 percent of workforce in Iran during 2018-19; while more
than 50 percent of them are employed in service occupa-
tions. Therefore, there is a higher likelihood for men to ac-
quire CoV infection due to higher social interactions in work
environments. Another common yet, forgotten aspect of the
issue is the masculinity and social norms among men that
hinder them from seeking medical help in times of need. It
is well-known that due to social and physiologic character-
istics, men tend to overlook their health and are incline to
seek medical help. This picture adds up to the previous prob-
lem of higher social movements, which leads to more contact
of healthy people with asymptomatic or mildly symptomatic
patients in community(35). In summary, apart from genetic
factors, there seems to be a constellation of demographic and
social factors contributing to higher incidence and mortal-
ity rates among men. Taking into account the role of gen-
der in the progression of COVID-19 epidemic may contribute
greatly to the control and containment measures, which itself
would help combating the pandemic.
3. Conclusion
Corona virus has a less fatality rate compared to other
viruses in the family such as SARS or MERS; nevertheless,
it shows unique propagation behaviours in human soci-
eties that make epidemic control measures difficult. Our re-
view showed that current knowledge supports the premise of
higher susceptibility of men to CoV infection, which is mainly
attributed to genetic traits and social profile. Health policy
makers and public health practitioners must take into ac-
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